BioELife Corp.
LITH · OTC
9/30/2019 | 6/30/2019 | 3/31/2019 | 12/31/2018 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $1 | $0 | $0 | $1 |
| Gross Profit | -$1 | -$0 | -$0 | -$1 |
| % Margin | – | – | – | – |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $20 | $22 | $26 | $22 |
| SG&A Expenses | $20 | $22 | $26 | $22 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $20 | $22 | $26 | $22 |
| Operating Income | -$21 | -$22 | -$26 | -$22 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | -$28 | -$84 | $106 | -$493 |
| Pre-Tax Income | -$48 | -$106 | $80 | -$515 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$48 | -$106 | $80 | -$515 |
| % Margin | – | – | – | – |
| EPS | -0.01 | -0.04 | 0.03 | -0.2 |
| % Growth | 74.3% | -232.3% | 115% | – |
| EPS Diluted | -0.01 | -0.04 | 0.03 | -0.2 |
| Weighted Avg Shares Out | 4,762 | 2,672 | 2,626 | 2,626 |
| Weighted Avg Shares Out Dil | 4,762 | 2,672 | 2,626 | 2,626 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $5 | $8 | $10 |
| Depreciation & Amortization | $1 | $0 | $0 | -$52 |
| EBITDA | -$47 | -$101 | $88 | -$506 |
| % Margin | – | – | – | – |